Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 9 |
NetGPI | no | yes: 0, no: 9 |
Related structures:
AlphaFold database: A4HE03
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 209 | 211 | PF00675 | 0.559 |
CLV_PCSK_FUR_1 | 260 | 264 | PF00082 | 0.539 |
CLV_PCSK_KEX2_1 | 209 | 211 | PF00082 | 0.539 |
CLV_PCSK_KEX2_1 | 262 | 264 | PF00082 | 0.654 |
CLV_PCSK_PC1ET2_1 | 209 | 211 | PF00082 | 0.539 |
CLV_PCSK_PC1ET2_1 | 262 | 264 | PF00082 | 0.654 |
CLV_PCSK_SKI1_1 | 276 | 280 | PF00082 | 0.792 |
DOC_ANK_TNKS_1 | 181 | 188 | PF00023 | 0.658 |
DOC_CYCLIN_yCln2_LP_2 | 166 | 172 | PF00134 | 0.616 |
DOC_CYCLIN_yCln2_LP_2 | 59 | 65 | PF00134 | 0.382 |
DOC_MAPK_MEF2A_6 | 135 | 143 | PF00069 | 0.440 |
DOC_MAPK_MEF2A_6 | 157 | 166 | PF00069 | 0.554 |
DOC_PP2B_LxvP_1 | 141 | 144 | PF13499 | 0.471 |
DOC_PP2B_LxvP_1 | 166 | 169 | PF13499 | 0.515 |
DOC_PP4_FxxP_1 | 202 | 205 | PF00568 | 0.447 |
DOC_USP7_MATH_1 | 144 | 148 | PF00917 | 0.474 |
DOC_USP7_MATH_1 | 221 | 225 | PF00917 | 0.708 |
DOC_USP7_UBL2_3 | 232 | 236 | PF12436 | 0.567 |
DOC_USP7_UBL2_3 | 270 | 274 | PF12436 | 0.637 |
DOC_USP7_UBL2_3 | 276 | 280 | PF12436 | 0.641 |
DOC_WW_Pin1_4 | 180 | 185 | PF00397 | 0.569 |
DOC_WW_Pin1_4 | 22 | 27 | PF00397 | 0.573 |
LIG_14-3-3_CanoR_1 | 263 | 267 | PF00244 | 0.690 |
LIG_14-3-3_CanoR_1 | 81 | 87 | PF00244 | 0.477 |
LIG_BRCT_BRCA1_1 | 59 | 63 | PF00533 | 0.390 |
LIG_EH_1 | 60 | 64 | PF12763 | 0.379 |
LIG_FHA_1 | 196 | 202 | PF00498 | 0.710 |
LIG_FHA_2 | 181 | 187 | PF00498 | 0.579 |
LIG_FHA_2 | 32 | 38 | PF00498 | 0.687 |
LIG_LIR_Apic_2 | 224 | 228 | PF02991 | 0.712 |
LIG_LIR_Gen_1 | 12 | 20 | PF02991 | 0.734 |
LIG_LIR_Gen_1 | 186 | 194 | PF02991 | 0.606 |
LIG_LIR_Gen_1 | 73 | 83 | PF02991 | 0.554 |
LIG_LIR_Nem_3 | 117 | 121 | PF02991 | 0.601 |
LIG_LIR_Nem_3 | 12 | 17 | PF02991 | 0.517 |
LIG_LIR_Nem_3 | 186 | 192 | PF02991 | 0.593 |
LIG_LIR_Nem_3 | 73 | 79 | PF02991 | 0.549 |
LIG_MYND_1 | 165 | 169 | PF01753 | 0.527 |
LIG_PTB_Apo_2 | 188 | 195 | PF02174 | 0.692 |
LIG_PTB_Phospho_1 | 188 | 194 | PF10480 | 0.691 |
LIG_RPA_C_Fungi | 251 | 263 | PF08784 | 0.508 |
LIG_SH2_CRK | 189 | 193 | PF00017 | 0.591 |
LIG_SH2_CRK | 225 | 229 | PF00017 | 0.720 |
LIG_SH2_CRK | 76 | 80 | PF00017 | 0.588 |
LIG_SH2_GRB2like | 189 | 192 | PF00017 | 0.694 |
LIG_SH2_PTP2 | 159 | 162 | PF00017 | 0.629 |
LIG_SH2_SRC | 159 | 162 | PF00017 | 0.629 |
LIG_SH2_STAP1 | 14 | 18 | PF00017 | 0.519 |
LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.492 |
LIG_SH2_STAT5 | 159 | 162 | PF00017 | 0.587 |
LIG_SH2_STAT5 | 229 | 232 | PF00017 | 0.680 |
LIG_SH3_1 | 159 | 165 | PF00018 | 0.626 |
LIG_SH3_3 | 159 | 165 | PF00018 | 0.540 |
LIG_SH3_3 | 227 | 233 | PF00018 | 0.669 |
LIG_SH3_3 | 23 | 29 | PF00018 | 0.617 |
LIG_SH3_4 | 232 | 239 | PF00018 | 0.586 |
LIG_SH3_4 | 268 | 275 | PF00018 | 0.749 |
LIG_SUMO_SIM_par_1 | 103 | 108 | PF11976 | 0.456 |
LIG_TRAF2_1 | 19 | 22 | PF00917 | 0.746 |
LIG_TRAF2_1 | 39 | 42 | PF00917 | 0.752 |
LIG_WRC_WIRS_1 | 83 | 88 | PF05994 | 0.567 |
MOD_CK1_1 | 110 | 116 | PF00069 | 0.567 |
MOD_CK1_1 | 117 | 123 | PF00069 | 0.525 |
MOD_CK1_1 | 147 | 153 | PF00069 | 0.585 |
MOD_CK2_1 | 180 | 186 | PF00069 | 0.580 |
MOD_GlcNHglycan | 123 | 126 | PF01048 | 0.484 |
MOD_GlcNHglycan | 14 | 17 | PF01048 | 0.552 |
MOD_GlcNHglycan | 146 | 149 | PF01048 | 0.712 |
MOD_GlcNHglycan | 202 | 205 | PF01048 | 0.713 |
MOD_GlcNHglycan | 256 | 259 | PF01048 | 0.610 |
MOD_GSK3_1 | 110 | 117 | PF00069 | 0.565 |
MOD_GSK3_1 | 252 | 259 | PF00069 | 0.606 |
MOD_N-GLC_1 | 133 | 138 | PF02516 | 0.478 |
MOD_N-GLC_1 | 22 | 27 | PF02516 | 0.675 |
MOD_N-GLC_1 | 31 | 36 | PF02516 | 0.739 |
MOD_NEK2_1 | 264 | 269 | PF00069 | 0.666 |
MOD_PIKK_1 | 195 | 201 | PF00454 | 0.714 |
MOD_PKA_1 | 262 | 268 | PF00069 | 0.690 |
MOD_PKA_2 | 262 | 268 | PF00069 | 0.689 |
MOD_Plk_1 | 107 | 113 | PF00069 | 0.580 |
MOD_Plk_1 | 133 | 139 | PF00069 | 0.484 |
MOD_Plk_1 | 31 | 37 | PF00069 | 0.761 |
MOD_Plk_4 | 107 | 113 | PF00069 | 0.550 |
MOD_Plk_4 | 114 | 120 | PF00069 | 0.556 |
MOD_Plk_4 | 31 | 37 | PF00069 | 0.551 |
MOD_Plk_4 | 75 | 81 | PF00069 | 0.547 |
MOD_ProDKin_1 | 180 | 186 | PF00069 | 0.575 |
MOD_ProDKin_1 | 22 | 28 | PF00069 | 0.573 |
MOD_SUMO_for_1 | 175 | 178 | PF00179 | 0.659 |
TRG_DiLeu_BaLyEn_6 | 162 | 167 | PF01217 | 0.522 |
TRG_ENDOCYTIC_2 | 14 | 17 | PF00928 | 0.520 |
TRG_ENDOCYTIC_2 | 189 | 192 | PF00928 | 0.548 |
TRG_ENDOCYTIC_2 | 76 | 79 | PF00928 | 0.592 |
TRG_NLS_Bipartite_1 | 262 | 278 | PF00514 | 0.706 |
TRG_NLS_MonoExtC_3 | 208 | 214 | PF00514 | 0.652 |
TRG_NLS_MonoExtN_4 | 206 | 213 | PF00514 | 0.445 |
TRG_NLS_MonoExtN_4 | 271 | 278 | PF00514 | 0.711 |
TRG_Pf-PMV_PEXEL_1 | 211 | 215 | PF00026 | 0.442 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P685 | Leptomonas seymouri | 52% | 94% |
A0A3Q8IC96 | Leishmania donovani | 71% | 100% |
A0A422NX50 | Trypanosoma rangeli | 31% | 100% |
A4I1B3 | Leishmania infantum | 71% | 100% |
D0A5K5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 28% | 100% |
E9AXE9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 69% | 100% |
Q4QA23 | Leishmania major | 69% | 100% |
V5BN56 | Trypanosoma cruzi | 29% | 100% |